149 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ARRY Array BioPharma Inc. $13.73 $2.91B N/A
Article Searches
Stocks To Watch: Tech Earnings Bellwethers Set To Test Rally https://seekingalpha.com/article/4212924-stocks-watch-tech-earnings-bellwethers-set-test-rally?source=feed Oct 20, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Your Cancer Highlight: Loxo Breaks Through Again, Now With Its Own Drug https://seekingalpha.com/article/4204799-cancer-highlight-loxo-breaks-now-drug?source=feed_sector_healthcare Sep 07, 2018 - Loxo is an important success story of our time, making big gains for investors and the oncology community alike.More breakthroughs give the company an important in to continue its growth.With a ceilin
Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates http://www.zacks.com/stock/news/311982/biotech-stock-roundup-amgn-resubmits-evenity-bla-advaxis-soars-regulatory-updates?cid=CS-ZC-FT-311982 Jul 18, 2018 - It has been a pretty ho-hum week for the biotech sector with a few regulatory updates. Amgen resubmits BLA for osteoporosis drug and Advaxis surges on positive news from FDA.
3 Things In Biotech, July 16: Array Gets An Important Update https://seekingalpha.com/article/4187583-3-things-biotech-july-16-array-gets-important-update?source=feed_all_articles Jul 16, 2018 - Array's melanoma combo gets a guideline nod. Atossa looks for a window of opportunity in breast cancer. Astellas and Pfizer score widened approval for Xtandi.
Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit ... http://www.gurufocus.com/news/707541/financial--investment-management-group-ltd-buys-omnicom-group-inc-blackrock-credit-allocation-income-trust-regeneron-pharmaceuticals-inc-sells-schwab-intermediateterm-us-treasury-associated-capital-group-inc-nokia-oyj Jul 13, 2018 - Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit Allocation Income Trust, Regeneron Pharmaceuticals Inc, Sells Schwab Intermediate-Term U.S. Treasury, Associated Capital Group Inc, Nokia Oyj, Stocks: OMC,BTZ,REGN,HBI,ARRY,IGR,AGIO,FWONK,BRK.A,GDO,FAX, release date:Jul 13, 2018
Wells Fargo Projects Sustained Growth For British Telecom Supplier Arris http://feeds.benzinga.com/~r/benzinga/~3/jt1j9bmt0QQ/wells-fargo-projects-sustained-growth-for-british-telec Jul 12, 2018 -

Wells Fargo initiated coverage of ARRIS International plc (NASDAQ: ARRS) with above-consensus estimates for 2018, 2019 and 2020.

Key FDA Events in June Investors Need to Watch Out For http://www.zacks.com/stock/news/306171/key-fda-events-in-june-investors-need-to-watch-out-for?cid=CS-ZC-FT-306171 Jun 01, 2018 - Investors in the healthcare industry are likely to keep a watch on upcoming PDUFA dates for key drugs in Jun 2018.
Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap https://seekingalpha.com/article/4178491-core-biotech-buys-17-positive-commentary-gene-therapy-first-swap?source=feed_tag_etf_portfolio_strategy May 31, 2018 - FDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme.A clinical hold for CRISPR Therapeutics caused some concern but I p
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas https://seekingalpha.com/article/4176184-core-biotech-buys-16-taking-advantage-weakness-add-conviction-ideas?source=feed_all_articles May 22, 2018 - Recent weakness in the biotech sector is an opportunity to add to conviction holdings.My ¨Week in Review¨ blog post appears to have the makings of a permanent feature due to positive feedback received
Lucky Seven: Bio Struggles, Achaogen Breaks Key Support https://seekingalpha.com/article/4176031-lucky-seven-bio-struggles-achaogen-breaks-key-support?source=feed_all_articles May 21, 2018 - Achaogen breaks key support.Aimmune Therapeutics is a buy.Immune Design keeps its head above water.

Pages: 123456...15

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ASND Ascendis Pharma A/S NASDAQ $68.28 $2.87B
BPMC Blueprint Medicines Corporation NASDAQ $68.7 $3.02B
HRTX Heron Therapeutics, Inc. NASDAQ $33.8 $2.63B
IRWD Ironwood Pharmaceuticals, Inc. NASDAQ $17.1 $2.62B
HZNP Horizon Pharma plc NASDAQ $19.22 $3.2B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Array BioPharma